Clinical trials
Completed Ankle Injuries trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
194 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2003 | 3 |
| 2004 | 1 |
| 2006 | 2 |
| 2007 | 3 |
| 2008 | 7 |
| 2009 | 9 |
| 2010 | 8 |
| 2011 | 4 |
| 2012 | 4 |
| 2013 | 7 |
| 2014 | 9 |
| 2015 | 5 |
| 2016 | 3 |
| 2017 | 8 |
| 2018 | 14 |
| 2019 | 16 |
| 2020 | 11 |
| 2021 | 13 |
| 2022 | 20 |
| 2023 | 21 |
| 2024 | 16 |
| 2025 | 8 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 194 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Novartis | 5 |
| Riphah International University | 5 |
| Acibadem University | 3 |
| Bahçeşehir University | 3 |
| Creighton University | 3 |
| Hisamitsu Pharmaceutical Co., Inc. | 3 |
| Istituto Ortopedico Rizzoli | 3 |
| London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's | 3 |
| Paragon 28 | 3 |
| University of Lahore | 3 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Ankle Injuries | 194 |
| Disease | 13 |
| Sprains and Strains | 13 |
| Foot Injuries | 12 |
| Joint Instability | 11 |
| Knee Injuries | 11 |
| Pain | 11 |
| Ankle Fractures | 9 |
| Wounds and Injuries | 9 |
| Athletic Injuries | 6 |
Trials
Showing 76 to 100 of 194. Each trial links to its page on Pharma Observatory.
94 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.